Penumbra Inc. (PEN)

166.49
0.27 0.16
NYSE : Health Technology
Prev Close 166.76
Open 167.35
Day Low/High 166.22 / 169.36
52 Wk Low/High 110.84 / 185.70
Volume 365.64K
Avg Volume 569.90K
Exchange NYSE
Shares Outstanding 34.91M
Market Cap 5.82B
EPS 0.20
P/E Ratio 133.41
Div & Yield N.A. (N.A)

Latest News

Penumbra Indigo® Aspiration System IDE Trial For Acute Pulmonary Embolism Meets Primary Safety And Efficacy Endpoints

Penumbra Indigo® Aspiration System IDE Trial For Acute Pulmonary Embolism Meets Primary Safety And Efficacy Endpoints

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced that the EXTRACT-PE trial successfully met the primary endpoints, demonstrating the safety and efficacy of the Indigo ® Aspiration System for...

Indigo® System CAT™ RX Aspiration Catheter And Penumbra ENGINE™. As Part Of The Indigo Aspiration System, The Indigo CAT RX Aspiration Catheters And Indigo Separator™ 4 Are Indicated For The Removal Of Fresh, Soft Emboli And Thrombi From Vessels In The Coronary And Peripheral Vasculature. (Photo: Business Wire)

Indigo® System CAT™ RX Aspiration Catheter And Penumbra ENGINE™. As Part Of The Indigo Aspiration System, The Indigo CAT RX Aspiration Catheters And Indigo Separator™ 4 Are Indicated For The Removal Of Fresh, Soft Emboli And Thrombi From Vessels In The Coronary And Peripheral Vasculature. (Photo: Business Wire)

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced enrollment of the first patient into the CHEETAH study, a prospective, multi-center U.

S&P Dow Jones Indices Announces Nine Companies Set To Join S&P MidCap 400; Ten Companies To Join S&P SmallCap 600

S&P Dow Jones Indices Announces Nine Companies Set To Join S&P MidCap 400; Ten Companies To Join S&P SmallCap 600

NEW YORK, Sept. 6, 2019 /PRNewswire/ -- S&P Dow Jones Indices will make the following index adjustments to the S&P MidCap 400 and S&P SmallCap 600 to ensure each index more appropriately represents its market capitalization range.

Sri Kosaraju Promoted To President And CFO Of Penumbra

Sri Kosaraju Promoted To President And CFO Of Penumbra

Kosaraju will add duties to his current responsibilities as chief financial officer

Penumbra, Inc. To Present At The 2019 Wells Fargo Healthcare Conference

Penumbra, Inc. To Present At The 2019 Wells Fargo Healthcare Conference

ALAMEDA, Calif., Aug.

Penumbra, Inc. Reports Second Quarter 2019 Financial Results

Penumbra, Inc. Reports Second Quarter 2019 Financial Results

ALAMEDA, Calif., Aug.

Penumbra JET™ 7 With XTRA FLEX Technology And Penumbra ENGINE™ (Photo: Business Wire)

Penumbra JET™ 7 With XTRA FLEX Technology And Penumbra ENGINE™ (Photo: Business Wire)

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.

Penumbra, Inc. To Present At The Canaccord Genuity 39th Annual Growth Conference

Penumbra, Inc. To Present At The Canaccord Genuity 39th Annual Growth Conference

ALAMEDA, Calif., July 17, 2019 /PRNewswire/ -- Penumbra, Inc.

Penumbra, Inc. Schedules Second Quarter 2019 Earnings Release And Conference Call For August 6, 2019

Penumbra, Inc. Schedules Second Quarter 2019 Earnings Release And Conference Call For August 6, 2019

ALAMEDA, Calif., July 16, 2019 /PRNewswire/ -- Penumbra, Inc.

Penumbra, Inc. To Present At The BMO 2019 Prescriptions For Success Healthcare Conference

Penumbra, Inc. To Present At The BMO 2019 Prescriptions For Success Healthcare Conference

ALAMEDA, Calif., June 11, 2019 /PRNewswire/ -- Penumbra, Inc.

Penumbra, Inc. To Present At The Goldman Sachs 40th Annual Global Healthcare Conference

Penumbra, Inc. To Present At The Goldman Sachs 40th Annual Global Healthcare Conference

ALAMEDA, Calif., May 29, 2019 /PRNewswire/ -- Penumbra, Inc.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AIRG, CPE, EVA, FBK, NTB, PEN, PJT, PTNR, RGNX Downgrades: HTBI, IMO, PJC, RDCM, SCHL Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Penumbra, Inc. Announces Acquisition Of Controlling Interest In MVI Health

Penumbra, Inc. Announces Acquisition Of Controlling Interest In MVI Health

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced it has closed on the acquisition of a controlling interest in its joint venture, MVI Health Inc.

Penumbra Launches Latest Advancements In Stroke Thrombectomy Aspiration Technology

Penumbra Launches Latest Advancements In Stroke Thrombectomy Aspiration Technology

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.

Independent Study Reaffirms Penumbra Aspiration As Frontline Thrombectomy Approach For Acute Ischemic Stroke

Independent Study Reaffirms Penumbra Aspiration As Frontline Thrombectomy Approach For Acute Ischemic Stroke

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced the presentation of the results of the COMPASS Trial, an independent, prospective, multi-center randomized...

Aspiration First Approach With Penumbra System Demonstrates Favorable Outcomes For Acute Ischemic Stroke

Aspiration First Approach With Penumbra System Demonstrates Favorable Outcomes For Acute Ischemic Stroke

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced results of the company-sponsored PROMISE Study, demonstrating real-world safety and efficacy of the Penumbra...

Penumbra Announces Key Events At International Stroke Conference 2018 Meeting

Penumbra Announces Key Events At International Stroke Conference 2018 Meeting

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced key events at the upcoming International Stroke Conference 2018 meeting (ISC 2018) to be held January 24-26 at...

Penumbra Announces The Formation Of Joint Venture, MVI Health

Penumbra Announces The Formation Of Joint Venture, MVI Health

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced it has entered into a joint venture called MVI Health Inc.

Long Live the FAANNG Stocks: Cramer's 'Mad Money' Recap (Tuesday 12/19/17)

Long Live the FAANNG Stocks: Cramer's 'Mad Money' Recap (Tuesday 12/19/17)

Reports of the death of Facebook, Apple, Amazon, Netflix, Nvidia and Google/Alphabet are greatly exaggerated, says Jim Cramer.

PEN Crosses Above Average Analyst Target

In recent trading, shares of Penumbra Inc have crossed above the average analyst 12-month target price of $89.00, changing hands for $89.30/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Penumbra Reaches Analyst Target Price

In recent trading, shares of Penumbra Inc have crossed above the average analyst 12-month target price of $87.67, changing hands for $88.35/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Deregulation and Energy Policy Can Fuel Markets: Cramer's 'Mad Money' Recap (Friday 3/17/17)

Deregulation and Energy Policy Can Fuel Markets: Cramer's 'Mad Money' Recap (Friday 3/17/17)

This week the markets fell back on earnings -- like Adobe -- and remained afloat, says Jim Cramer.

There Is a $10 Million Job Now Up for Grabs -- Think You Can Get It?

There Is a $10 Million Job Now Up for Grabs -- Think You Can Get It?

The job scene is good only if you're in the right sector.

Penumbra Reaches Analyst Target Price

In recent trading, shares of Penumbra Inc have crossed above the average analyst 12-month target price of $82.67, changing hands for $83.25/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Notable Thursday Option Activity: PEN, NTNX, ILG

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Penumbra Inc , where a total volume of 3,012 contracts has been traded thus far today, a contract volume which is representative of approximately 301,200 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 141% of PEN's average daily trading volume over the past month, of 213,550 shares.

Penumbra Announces Key Events At Society Of Interventional Radiology 2017 Meeting

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on interventional therapies, today announced key events at the upcoming Society of Interventional Radiology 2017 meeting (SIR 2017) to be held March 4-9...

TheStreet Quant Rating: C+ (Hold)